Copyright Reports & Markets. All rights reserved.

Global Bladder Cancer Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Bladder Cancer

      • 1.1 Definition of Bladder Cancer
      • 1.2 Bladder Cancer Segment by Type
        • 1.2.1 Global Bladder Cancer Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Intravesical therapy
        • 1.2.3 Chemotherapy
        • 1.2.4 Preservation therapy
      • 1.3 Bladder Cancer Segment by Applications
        • 1.3.1 Global Bladder Cancer Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
      • 1.4 Global Bladder Cancer Overall Market
        • 1.4.1 Global Bladder Cancer Revenue (2014-2025)
        • 1.4.2 Global Bladder Cancer Production (2014-2025)
        • 1.4.3 North America Bladder Cancer Status and Prospect (2014-2025)
        • 1.4.4 Europe Bladder Cancer Status and Prospect (2014-2025)
        • 1.4.5 China Bladder Cancer Status and Prospect (2014-2025)
        • 1.4.6 Japan Bladder Cancer Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Bladder Cancer Status and Prospect (2014-2025)
        • 1.4.8 India Bladder Cancer Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Bladder Cancer
      • 2.3 Manufacturing Process Analysis of Bladder Cancer
      • 2.4 Industry Chain Structure of Bladder Cancer

      3 Development and Manufacturing Plants Analysis of Bladder Cancer

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Bladder Cancer Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Bladder Cancer
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Bladder Cancer Production and Capacity Analysis
      • 4.2 Bladder Cancer Revenue Analysis
      • 4.3 Bladder Cancer Price Analysis
      • 4.4 Market Concentration Degree

      5 Bladder Cancer Regional Market Analysis

      • 5.1 Bladder Cancer Production by Regions
        • 5.1.1 Global Bladder Cancer Production by Regions
        • 5.1.2 Global Bladder Cancer Revenue by Regions
      • 5.2 Bladder Cancer Consumption by Regions
      • 5.3 North America Bladder Cancer Market Analysis
        • 5.3.1 North America Bladder Cancer Production
        • 5.3.2 North America Bladder Cancer Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Bladder Cancer Import and Export
      • 5.4 Europe Bladder Cancer Market Analysis
        • 5.4.1 Europe Bladder Cancer Production
        • 5.4.2 Europe Bladder Cancer Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Bladder Cancer Import and Export
      • 5.5 China Bladder Cancer Market Analysis
        • 5.5.1 China Bladder Cancer Production
        • 5.5.2 China Bladder Cancer Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Bladder Cancer Import and Export
      • 5.6 Japan Bladder Cancer Market Analysis
        • 5.6.1 Japan Bladder Cancer Production
        • 5.6.2 Japan Bladder Cancer Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Bladder Cancer Import and Export
      • 5.7 Southeast Asia Bladder Cancer Market Analysis
        • 5.7.1 Southeast Asia Bladder Cancer Production
        • 5.7.2 Southeast Asia Bladder Cancer Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Bladder Cancer Import and Export
      • 5.8 India Bladder Cancer Market Analysis
        • 5.8.1 India Bladder Cancer Production
        • 5.8.2 India Bladder Cancer Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Bladder Cancer Import and Export

      6 Bladder Cancer Segment Market Analysis (by Type)

      • 6.1 Global Bladder Cancer Production by Type
      • 6.2 Global Bladder Cancer Revenue by Type
      • 6.3 Bladder Cancer Price by Type

      7 Bladder Cancer Segment Market Analysis (by Application)

      • 7.1 Global Bladder Cancer Consumption by Application
      • 7.2 Global Bladder Cancer Consumption Market Share by Application (2014-2019)

      8 Bladder Cancer Major Manufacturers Analysis

      • 8.1 Bristol-Myers Squibb
        • 8.1.1 Bristol-Myers Squibb Bladder Cancer Production Sites and Area Served
        • 8.1.2 Bristol-Myers Squibb Product Introduction, Application and Specification
        • 8.1.3 Bristol-Myers Squibb Bladder Cancer Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Eli Lilly
        • 8.2.1 Eli Lilly Bladder Cancer Production Sites and Area Served
        • 8.2.2 Eli Lilly Product Introduction, Application and Specification
        • 8.2.3 Eli Lilly Bladder Cancer Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 F. Hoffman-La Roche
        • 8.3.1 F. Hoffman-La Roche Bladder Cancer Production Sites and Area Served
        • 8.3.2 F. Hoffman-La Roche Product Introduction, Application and Specification
        • 8.3.3 F. Hoffman-La Roche Bladder Cancer Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Pfizer
        • 8.4.1 Pfizer Bladder Cancer Production Sites and Area Served
        • 8.4.2 Pfizer Product Introduction, Application and Specification
        • 8.4.3 Pfizer Bladder Cancer Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Accord Healthcare
        • 8.5.1 Accord Healthcare Bladder Cancer Production Sites and Area Served
        • 8.5.2 Accord Healthcare Product Introduction, Application and Specification
        • 8.5.3 Accord Healthcare Bladder Cancer Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 AstraZeneca
        • 8.6.1 AstraZeneca Bladder Cancer Production Sites and Area Served
        • 8.6.2 AstraZeneca Product Introduction, Application and Specification
        • 8.6.3 AstraZeneca Bladder Cancer Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Bedford Lab
        • 8.7.1 Bedford Lab Bladder Cancer Production Sites and Area Served
        • 8.7.2 Bedford Lab Product Introduction, Application and Specification
        • 8.7.3 Bedford Lab Bladder Cancer Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Merck
        • 8.8.1 Merck Bladder Cancer Production Sites and Area Served
        • 8.8.2 Merck Product Introduction, Application and Specification
        • 8.8.3 Merck Bladder Cancer Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Sanofi
        • 8.9.1 Sanofi Bladder Cancer Production Sites and Area Served
        • 8.9.2 Sanofi Product Introduction, Application and Specification
        • 8.9.3 Sanofi Bladder Cancer Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served

      9 Development Trend of Analysis of Bladder Cancer Market

      • 9.1 Global Bladder Cancer Market Trend Analysis
        • 9.1.1 Global Bladder Cancer Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Bladder Cancer Regional Market Trend
        • 9.2.1 North America Bladder Cancer Forecast 2019-2025
        • 9.2.2 Europe Bladder Cancer Forecast 2019-2025
        • 9.2.3 China Bladder Cancer Forecast 2019-2025
        • 9.2.4 Japan Bladder Cancer Forecast 2019-2025
        • 9.2.5 Southeast Asia Bladder Cancer Forecast 2019-2025
        • 9.2.6 India Bladder Cancer Forecast 2019-2025
      • 9.3 Bladder Cancer Market Trend (Product Type)
      • 9.4 Bladder Cancer Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Bladder Cancer Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Bladder cancer is known to be a urologic malignancy that occurs in the tissues of the urinary bladder. It is generally characterized by the uncontrolled division of cells arising from the epithelial lining and may proliferate to the muscular wall of the urinary bladder. The exact causes of bladder cancer are still unknown.

        The global Bladder Cancer market was valued at 460 million US$ in 2018 and will reach 1140 million US$ by the end of 2025, growing at a CAGR of 12.1% during 2019-2025.
        This report focuses on Bladder Cancer volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bladder Cancer market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Bladder Cancer in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Bladder Cancer manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Bristol-Myers Squibb
        Eli Lilly
        F. Hoffman-La Roche
        Pfizer
        Accord Healthcare
        AstraZeneca
        Bedford Lab
        Merck
        Sanofi

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Intravesical therapy
        Chemotherapy
        Preservation therapy

        Segment by Application
        Hospital
        Clinic

        Buy now